Elevated levels of soluble intercellular adhesion molecule-1 in the coronary circulation of patients with coronary organic stenosis and spasm

Japanese Circulation Journal

Volumn 64, Issue 3, 2000, Pages 170-176

  Ogawa, Hisao ^a   Sakamoto, Tomohiro ^a   Nishiyama, Koichi ^a   Soejima, Hirofumi ^a   Kaikita, Koichi ^a   Takazoe, Keiji ^a   Miyamoto, Shinzo ^a   Kugiyama, Kiyotaka ^a   Yoshimura, Michihiro ^a   Yasue, Hirofumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Coronary circulation; Coronary organic stenosis; Coronary spastic angina; Soluble intercellular adhesion molecule 1 (sICAM 1)

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ANGINA PECTORIS; AORTA ROOT; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; CORONARY SINUS; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; MALE; PROTEIN EXPRESSION;

AGED; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VASOSPASM; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED;

EID: 0346107337     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.64.170     Document Type: Article

References (46)

1. Yasue H, Omote S, Takizawa A Nagano M: Coronary arterial spasm in ischemic heart disease and its pathogenesis. Circ Res 1983; 52(Suppl I): 147-152
2. Fuster V, Chesebro JH: Mechanisms of unstable angina. N Engl J Med 1986; 315: 1023-1025
3. Maseri A, Severi S, De Nes DM, L'Abbate A, Chierchia S, Marzilli M, et al: 'Variant' angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Am J Cardiol 1978; 42: 1019-1035
4. Oshima S, Ogawa H, Yasue H, Okumura K, Matsuyama K, Miyagi H: Increased plasma fibrinopeptide A levels during attacks induced by hyperventilation in patients with coronary vasospastic angina. J Am Coll Cardiol 1989; 14: 150-154
5. Ogawa H, Yasue H, Oshima S, Okumura K, Matsuyama K, Obata K: Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation 1989; 80: 1617-1626
6. Oshima S, Yasue H, Ogawa H, Okumura K, Matsuyama K: Fibrinopeptide A is released into the coronary circulation after coronary spasm. Circulation 1990; 82: 2222-2225
7. Masuda T, Yasue H, Ogawa H, Misumi I, Sakamoto T, Okubo H et al: Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina. Am Heart J 1992; 124: 314-319
8. Masuda T, Ogawa H, Miyao Y, Yu Q, Misumi I, Sakamoto T, et al: Circadian variation in fibrinolytic activity in patients with variant angina. Br Heart J 1994; 71: 156-161
9. Hillis LD, Braunwald E: Coronary artery spasm. N Engl J Med 1978; 299: 695-702
10. Yasue H, Omote S, Takizawa A, Nagao M, Hyon H, Nishida S, et al: Comparison of coronary arteriographic findings during angina pectoris associated with S-T elevation or depression. Am J Cardiol 1981; 47: 539-546
11. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, et al: Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986; 74: 955-963
12. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al: Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1-9
13. Buja LM, Willerson JT: Clinicopathologic correlates of acute ischemic heart disease syndromes. Am J Cardiol 1981; 47: 343-356
14. van der Wal AC, Becker AE, van der Loos CM, Das PK: Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44
15. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, et al: Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88: 358-363
16. Diamond MS, Staunton DE, de Fougerollers AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, et al: ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 1990; 3: 3129-3141
17. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD: A form of circulating ICAM-I in human serum. J Immunol 1991; 147: 3788-3793
18. Gearing AJH, Newman W: Circulating adhesion molecules in disease, Immunol Today 1993; 14: 506-512
19. Ogawa H, Yasue H, Miyao Y, Sakamoto T, Soejima H, Nishiyama K, et al: Plasma soluble intercellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina. Am J Cardiol 1999; 83: 38-42
20. Kaikita K, Ogawa H, Yasue H, Sakamoto T, Miyao Y, Suefuji H, et al: Increased plasma soluble intercellular adhesion molecule-1 levels in patients with acute myocardial infarction. Jpn Circ J 1997; 61: 741-748
21. Pigott R, Dillon LP, Hemingway IH, Gearing AJH: Soluble forms of E-selectin, ICAM-I and VCAM-I are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophvs Res Commun 1992; 187: 584-589
22. Giavazzi R, Chirivi RGS, Garofalo A, Rambaldi A, Hemingway I, Pigott R: Soluble intercellular adhesion molecule I is released by human melanoma cells and is associated with tumor growth in nude mice. Cancer Res 1992; 52: 2628-2630
23. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-2101
24. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ, Virmani R: Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med 1985; 313: 1138-1141
25. Kohchi K, Takebayashi S, Hiroki T, Nobuyoshi M: Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation 1985; 71: 709-716
26. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992; 140: 665-673
27. Ma X-I, Lefer DJ, Lefer AM, Rothlein R: Coronary endothelial and cardiac proiective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992; 86: 937-946
28. Blann AD, McCollum CN: Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 1994; 72: 151-154
29. Hwang S-J, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM, et al: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997; 96: 4219-4225
30. Haught WH, Mansour M, Rothlein R, Kishimoto TK, Mainolfi EA, Hendricks JB, et al: Alterations in circulating intercellular adhesion molecule-1 and L-selectin: Further evidence for chronic inflammation in ischemic heart disease. Am Heart J 1996; 132: 1-8
31. Shyu K-G, Chang H, Lin C-C, Kuan P: Circulating intercellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome. Chest 1996; 109: 1627-1630
32. Ghaisas NK, Shai CN, Foley B, Goggins M, Crean P, Kelly A, et al: Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Am J Cardiol 1997; 80: 617-619
33. Qi J, Kreutzer DL, Piela-Smith TH: Fibrin induction of ICAM-1 expression in human vascular endothelial cells. J Immunol 1997; 158: 1880-1886
34. Lefer AM, Weyrich AS, Buerke M: Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res 1994; 28: 289-294
35. Kaikita K, Ogawa H, Yasue H, Sakamoto T, Suefuji H, Sumida H, et al: Soluble P-selectin is released into the coronary circulation after coronary spasm. Circulation 1995; 92: 1726-1730
36. Miwa K, Igawa A, Inoue H: Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc Res 1997; 36: 37-44
37. Ceriello A, Falleti E, Bortolotti N, Motz E, Cavarape A, Russo A, et al: Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism 1996; 45: 498-501
38. Hackman A, Abe Y, Insull W Jr, Pownall H, Smith L, Dunn K, et al: Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996; 93: 1334-1338
39. Blann AD, Steele C, McCollum CN: The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res 1997; 85: 433-438
40. Faint RW: Platelet-neutrophil interactions: their significance. Blood Rev 1992; 6: 83-91
41. De Servi S, Ricevuti G, Mazzone A, Pasotti D, Bramucci E, Angoli L, et al: Transcardiac release of leukotriene C4 by neutrophils in patients with coronary artery disease. J Am Coll Cardiol 1991; 17: 1125-1128
42. Feurstein G, Hallenbeck JM: Leukotrienes in health and disease. FASEB J 1987; 1: 186-192
43. Seven S, Davies G, Maseri A, Marzullo P, L'Abbate A: Long-term prognosis of 'variant' angina with medical treatment. Am J Cardiol 1980; 46: 226-232
44. Waters DD, Miller DD, Szlachcic J, Bouchard A, Methe M, Kreeft J, et al: Factors influencing the long-term prognosis of treated patients with variant angina. Circulation 1983; 68: 258-265
45. Mark DB, Califf RM, Morris KG, Harrell FE Jr, Pryor DB, Hlatky MA, et al: Clinical characteristics and long-term survival of patients with variant angina. Circulation 1984; 69: 880-888
46. Walling A. Waters DD, Miller DD, Roy D, Pelletier GB, Théroux P: Long-term prognosis of patients with variant angina. Circulation 1987; 76: 990-997